• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Topic:

  • Neuromuscular and Clinical Neurophysiology (EMG)

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 16 - 20 of 216

  • Page:
  • 2
  • 3
  • 4
  • 5
  • 6

Preliminary Efficacy and Safety Data from the Phase 2 Trial of Riliprubart (SAR445088), a Humanized Monoclonal Antibody Targeting Complement C1s, in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Author:Querol, Luis   Lewis, Richard   Hartung, Hans-Peter   Van Doorn, Pieter   Wallstroem, Erik   Luo, Xiaodong   Alonso Alonso, Miguel   Atassi, Nazem   Hughes, Richard   

Session Name:S15: Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S15.008  

Author Institution:Hospital de la Santa Creu i Sant Pau, Barcelona, Spain  Cedars Sinai Medical Center, Los Angeles, CA  Heinrich Heine University , Dusseldorf, Germany  Erasmus MC, University Medical Center, Rotterdam, Netherlands  Sanofi R&D, Neurology Development, Cambridge, MA  Sanofi R&D, Biostatistics and Programming, Bridgewater, NJ  UCL Queen Square Institute of Neurology, University College London, London, United Kingdom  

  • View Abstract
  • View Disclosure

Characterizing Monomelic Presentations of Demyelinating Neuropathy, or “Chronic Inflammatory Demyelinating Mononeuropathy” (CIDM)

Author:Swart, Grace   Shelly, Shahar   Lamb, Christopher   Pinto, Marcus Vinicius   Beecher, Grayson   Aragon Pinto, Catarina   Klein, Christopher   Engelstad, JaNean   Amrami, Kimberly   Spinner, Robert   Dyck, P. James B.   

Session Name:S15: Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S15.009  

Author Institution:Mayo Clinic, Rochester, MN  Rambam Medical Center, Haifa, Israel  Mayo Clinic, Jacksonville, FL  University of Alberta, Edmonton, AB, Canada  

  • View Abstract
  • View Disclosure

Long-term Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement Inhibitor, in Adults with Anti-acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis: Final Results from the Phase 3 CHAMPION MG Open-label Extension

Author:Vu, Tuan   Mantegazza, Renato   Annane, Djillali   Katsuno, Masahisa   Meisel, Andreas   Nicolle, Michael   Bril, Vera   Aguzzi, Rasha   Frick, Glen   Howard, James   

Session Name:S15: Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S15.010  

Author Institution:University of South Florida Morsani College of Medicine, Tampa, FL  Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy  Hôpital Raymond Poincaré, Garches, France  Nagoya University Graduate School of Medicine, Nagoya, Japan  Charité Universitätsmedizin Berlin, Berlin, Germany  London Health Sciences Centre, London, ON, Canada  University of Toronto, Toronto, ON, Canada  Alexion, AstraZeneca Rare Disease, Boston, MA  The University of North Carolina, Chapel Hill, NC  

  • View Abstract
  • View Disclosure

Ataluren Delays Clinically Meaningful Milestones of Decline in 6WMD in Patients with nmDMD from Study 041, a Phase 3, Placebo-controlled Trial

Author:Wu, Shiwen   Gulati, Sheffali   Komaki, Hirofumi   Escobar-Cedillo, Rosa E   Kostera-Prusczyk, Anna   Shin, Jin-Hong   Haginoya, Kazuhiro   Penematsa, Vinay   Chou, Connie   Williams, Paula   Werner, Christian   Statland, Jeffrey   

Session Name:S21: Inherited Myopathies and Neuropathies: New Therapeutic Approaches and Observations  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S21.001  

Author Institution:Third Medical Center of PLA, Beijing, China, People's Republic of  All India Institute of Medical Sciences, Ansari Nagar, India  National Center of Neurology ad Psychiatry, Tokyo, Japan  Instituto Nacional de Rehabilitacion, Mexico City, Mexico  Medical University of Warsaw, Warsaw, Poland  Pusan National University Yangsan Hospital, Yangsan, Korea, Republic of  Miyagi Children'S Hospital, Sendai, Japan  PTC Therapeutics, Inc, South Plainfield, NJ  PTC Therapeutics, Inc., South Plainfield, NJ  PTC Therapeutics,GmBH, Frankfurt, Germany  University of Kansas Medical Center, Kansas City, KS  

  • View Abstract
  • View Disclosure

Effects of EDG-5506, a Fast Myosin Modulator, on Function and Biomarkers of Muscle Damage in Adults with Becker Muscular Dystrophy

Author:Phan, Han   Collins, Samuel   Russell, Alan   Barthel, Ben   Thaler, Liz   Kilburn, Nicole   Mancini, Maria   MacDougall, James   Donovan, Joanne   

Session Name:S21: Inherited Myopathies and Neuropathies: New Therapeutic Approaches and Observations  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S21.002  

Author Institution:Rare Disease Research, Atlanta, GA  Edgewise Therapeutics, Christchurch, United Kingdom  Edgewise Therapeutics, Boulder, CO  Edgewise Therapeutics, Topsfield, MA  Edgewise Therapeutics, Boston, MA  Edgewise Therapeutics, Haverhill, MA  

  • View Abstract
  • View Disclosure

Displaying 16 - 20 of 216

  • Page:
  • 2
  • 3
  • 4
  • 5
  • 6

© 2015 Mira Smart Conference | http://www.mirasmart.com